Tag Archives: Centers for Disease Control and Prevention

Vaccine Distribution, Supply Chain, Testing Still Present Challenges in Federal Pandemic Response

Since November 2020, the number of COVID-19 cases in the U.S. has dramatically increased, further straining health care systems across the country. Today’s WatchBlog looks at our newest report on the federal pandemic response, which describes the status of ongoing … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , , , , , , | Leave a comment

COVID-19 Vaccines and the Lessons Learned from H1N1

As the federal government responds to the coronavirus pandemic, we here at GAO have been monitoring the response efforts—including reviewing COVID-19 vaccine development and authorization. Today’s WatchBlog explores our past work on vaccine distribution and lessons learned from the H1N1 … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , , , | Leave a comment

Why is CDC Screening Fewer People for Breast and Cervical Cancer?

About 265,000 women in the U.S. were diagnosed with breast or cervical cancer in 2017, according to the most recently available data from the Centers for Disease Control and Prevention. Early screening and detection of cancer, followed by prompt treatment, … Continue reading

Posted in About GAO, Collections, Health Care | Tagged , , , , , , , | Leave a comment

Continued Surge in COVID Cases Highlights Need for Urgent Federal Action

COVID-19 cases have been increasing since mid-September, further highlighting the importance of federal public health and economic response efforts. Today’s WatchBlog looks at our fourth report on the federal pandemic response, which describes the status of ongoing efforts and outlines … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , , , , , | Leave a comment

Operation Warp Speed—Federal Efforts to Accelerate COVID-19 Vaccine and Therapeutic Development

Note: This blog was updated on December 7 to clarify some references to the distribution and licensing aspects of a COVID-19 vaccine. Developing a vaccine can take 10 years or longer. However, as COVID-19 cases rapidly rose during the early … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , | Leave a comment

How Can the Federal Government Strengthen Its Response to COVID-19?

Today’s WatchBlog looks at our third report on the implementation of the CARES Act and other pandemic relief measures. The report outlines the many effective steps the Administration and the Congress have taken to address issues, and identifies further steps … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , , , , , , , , | Leave a comment

The Challenges of Going Back to School

States and local governments are grappling with how to bring K-12 students back to school safely amidst the COVID-19 pandemic—whether in person, virtually, or via a hybrid model. Yet, even before COVID-19, several schools across the country had to close … Continue reading

Posted in About GAO, Education, Podcast | Tagged , , , , , , , , , , , , | Leave a comment

Disease modeling: How Math Can Help In A Pandemic

The COVID-19 pandemic has brought new attention to models of infectious disease. These models are critical tools that scientists—including those from the Centers for Disease Control and Prevention (CDC)—use to anticipate health care needs and explore options for responding to … Continue reading

Posted in About GAO, Collections, Coronavirus | Tagged , , , , , , , , | Leave a comment

Superbugs: Antibiotic-Resistant Bacterial Infections on the Rise

Some bacterial infections have become difficult, and sometimes impossible, to treat. That’s because the “superbugs” causing these infections have developed the ability to defeat antibiotics—the drugs designed to kill them. While antibiotics do not work on viral diseases like COVID-19, … Continue reading

Posted in About GAO | Tagged , , , , , , , , | Leave a comment

Asking the Right Questions: How Many Medicare Participants Are At Risk of Harm from Prescription Opioids?

Over 14 million Medicare participants received opioid prescriptions in 2016—which cost the government over $4 billion. Because of the recent increase in opioid overdoses, Medicare monitors participants that might be overutilizing opioids. However, we found that there are more Medicare … Continue reading

Posted in Health Care | Tagged , , , , , | Leave a comment